Bpifrance SA Long-Term Concentrated

CIK: 0001731118 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: May 13, 2021

Total Value ($000): $3,960,743 (100.0% shares, 0.0% debt)

Holdings (7)

STLA STELLANTIS NV 86.0%

Value ($000) $3,407,256 Shares 192,703,907 Est. Cost $17.68 Unrealized —

— CONSTELLIUM NV 6.1%

Value ($000) $240,990 Shares 16,393,903 Est. Cost $6.99 Unrealized —

FTI TECHNIPFMC PLC 4.8%

Value ($000) $188,564 Shares 24,688,691 Est. Cost $17.41 Unrealized -53.9%

CRTO CRITEO S A 2.4%

Value ($000) $94,422 Shares 2,718,752 Est. Cost $22.72 Unrealized —

— SEQUANS COMMUNICATIONS S A 0.5%

Value ($000) $19,932 Shares 3,300,018 Est. Cost $1.45 Unrealized —

— CELLECTIS 0.2%

Value ($000) $8,604 Shares 425,726 Est. Cost $18.50 Unrealized —

CRSP CRISPR THERAPEUTICS AG 0.0%

Value ($000) $975 Shares 8,000 Est. Cost $151.00 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
STLA	STELLANTIS NV	192,703,907	$3,407,256	86.0%	$17.68	—	COM	N82405106
—	CONSTELLIUM NV	16,393,903	$240,990	6.1%	$6.99	—	CL A	N22035104
FTI	TECHNIPFMC PLC	24,688,691	$188,564	4.8%	$17.41	-53.9%	COM	G87110105
CRTO	CRITEO S A	2,718,752	$94,422	2.4%	$22.72	—	SPONS ADS	226718104
—	SEQUANS COMMUNICATIONS S A	3,300,018	$19,932	0.5%	$1.45	—	SPONS ADS	817323108
—	CELLECTIS	425,726	$8,604	0.2%	$18.50	—	SPONS ADS	15117k103
CRSP	CRISPR THERAPEUTICS AG	8,000	$975	0.0%	$151.00	0.0%	COM	H17182108